LTFS
GALT icon

Ladenburg Thalmann Financial Services’s Galectin Therapeutics GALT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$4K Hold
1,385
– – ﹤0.01% 4850
2019
Q3 		$5K Hold
1,385
– – ﹤0.01% 4679
2019
Q2 		$6K Buy
1,385
+385
+39% +$1.67K ﹤0.01% 4635
2019
Q1 		$5K Hold
1,000
– – ﹤0.01% 4654
2018
Q4 		$3K Buy
+1,000
New +$4.78K ﹤0.01% 4765
2018
Q3 		– Sell
-2,000
Closed -$9K – 5203
2018
Q2 		$9K Hold
2,000
– – ﹤0.01% 4295
2018
Q1 		$9K Hold
2,000
– – ﹤0.01% 4295
2017
Q4 		$7K Hold
2,000
– – ﹤0.01% 4367
2017
Q3 		$4K Buy
+2,000
New +$3.96K ﹤0.01% 4470
2016
Q4 		– Sell
-708
Closed -$1K – 4871
2016
Q3 		$1K Hold
708
– – ﹤0.01% 4611
2016
Q2 		$1K Hold
708
– – ﹤0.01% 4558
2016
Q1 		$1K Hold
708
– – ﹤0.01% 4510
2015
Q4 		$1K Hold
708
– – ﹤0.01% 4503
2015
Q3 		$2K Hold
708
– – ﹤0.01% 4254
2015
Q2 		$2K Sell
708
-119
-14% -$359 ﹤0.01% 4338
2015
Q1 		$3K Hold
827
– – ﹤0.01% 4157
2014
Q4 		$3K Buy
827
+119
+17% +$526 ﹤0.01% 3914
2014
Q3 		$4K Buy
708
+208
+42% +$1.62K ﹤0.01% 3478
2014
Q2 		$7K Hold
500
– – ﹤0.01% 3237
2014
Q1 		$8K Hold
500
– – ﹤0.01% 3064
2013
Q4 		$4K Sell
500
-26,072
-98% -$241K ﹤0.01% 3317
2013
Q3 		$198K Buy
26,572
+25,572
+2,557% +$173K 0.01% 1013
2013
Q2 		$4K Buy
+1,000
New +$4.09K ﹤0.01% 3131

Other funds holding GALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's GALT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Galectin Therapeutics (GALT) position steady in Q4 2019 at 1,385 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4850.

Ladenburg Thalmann Financial Services first reported a position in GALT in Q2 2013 and has held it in 23 quarters since. The position peaked at $198K in Q3 2013. 78 funds tracked by Wall St. Rank hold GALT as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,385 shares of Galectin Therapeutics worth $4K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Galectin Therapeutics share count unchanged in Q4 2019.
  • Galectin Therapeutics made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4850 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Galectin Therapeutics in Q2 2013 and has held it in 23 quarters since.
  • Ladenburg Thalmann Financial Services's Galectin Therapeutics position peaked at $198K in Q3 2013.
  • 78 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.